日期 影响因子
日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:
–

Assessment of Developmental Prosopagnosia in an Individual with Tourette Syndrome and Attention Deficit Hyperactivity Disorder: A Case Report

对一名患有图雷特综合征和注意力缺陷多动障碍的个体进行发育性面容失认症评估：病例报告

期刊:Brain Sciences
影响因子:2.8
doi:10.3390/brainsci15010056
Emhjellen, Petter Espeseth; Starrfelt, Randi; Raudeberg, Rune; Hassel, Bjørnar
发育与干细胞
发表日期：2025
文献求助 收藏

Relative vaccine effectiveness against COVID-19 hospitalisation in persons aged ≥ 65 years: results from a VEBIS network, Europe, October 2021 to July 2023

疫苗对≥65岁人群COVID-19住院治疗的相对有效性：来自欧洲VEBIS网络2021年10月至2023年7月的结果

期刊:Eurosurveillance
影响因子:7.8
doi:10.2807/1560-7917.ES.2024.29.1.2300670
Fontán-Vela, Mario; Kissling, Esther; Nicolay, Nathalie; Braeye, Toon; Van Evercooren, Izaak; Holm Hansen, Christian; Emborg, Hanne-Dorthe; Fabiani, Massimo; Mateo-Urdiales, Alberto; AlKerwi, Ala'a; Schmitz, Susanne; Castilla, Jesús; Martínez-Baz, Iván; de Gier, Brechje; Hahné, Susan; Meijerink, Hinta; Starrfelt, Jostein; Nunes, Baltazar; Caetano, Constantino; Derrough, Tarik; Nardone, Anthony; Monge, Susana
发表日期：2024
文献求助 收藏

Estimating vaccine effectiveness against COVID-19 using cause-specific sick leave as an indicator: a nationwide population-based cohort study, Norway, July 2021 - December 2022

以特定病假为指标评估新冠疫苗有效性：一项基于挪威全国人口的队列研究，2021年7月至2022年12月

期刊:BMC Public Health
影响因子:3.6
doi:10.1186/s12889-024-19374-0
Meijerink, Hinta; Veneti, Lamprini; Kristoffersen, Anja Bråthen; Danielsen, Anders Skyrud; Stecher, Melanie; Starrfelt, Jostein
微生物学
新冠
发表日期：2024
文献求助 收藏

Evidence for a Classical Dissociation between Face and Object Recognition in Developmental Prosopagnosia

发展性面容失认症中面孔识别和物体识别之间存在经典分离的证据

期刊:Brain Sciences
影响因子:2.8
doi:10.3390/brainsci14010107
Gerlach, Christian; Starrfelt, Randi
发表日期：2024
文献求助 收藏

Comparative effectiveness of heterologous third dose vaccine schedules against severe covid-19 during omicron predominance in Nordic countries: population based cohort analyses

在北欧国家奥密克戎毒株占主导地位期间，异源第三剂疫苗接种方案对重症新冠肺炎的比较有效性：基于人群的队列分析

期刊:Bmj-British Medical Journal
影响因子:42.7
doi:10.1136/bmj-2022-074325
Andersson, Niklas Worm; Thiesson, Emilia Myrup; Baum, Ulrike; Pihlström, Nicklas; Starrfelt, Jostein; Faksová, Kristýna; Poukka, Eero; Lund, Lars Christian; Hansen, Christian Holm; Aakjær, Mia; Kjær, Jesper; Cohet, Catherine; Goossens, Mathijs; Andersen, Morten; Hallas, Jesper; Meijerink, Hinta; Ljung, Rickard; Hviid, Anders
新冠
肺炎
微生物学
发表日期：2023
文献求助 收藏

Comparative effectiveness of bivalent BA.4-5 and BA.1 mRNA booster vaccines among adults aged ≥50 years in Nordic countries: nationwide cohort study

北欧国家50岁及以上成年人中二价BA.4-5和BA.1 mRNA加强疫苗的比较有效性：全国性队列研究

期刊:Bmj-British Medical Journal
影响因子:42.7
doi:10.1136/bmj-2022-075286
Andersson, Niklas Worm; Thiesson, Emilia Myrup; Baum, Ulrike; Pihlström, Nicklas; Starrfelt, Jostein; Faksová, Kristýna; Poukka, Eero; Meijerink, Hinta; Ljung, Rickard; Hviid, Anders
发表日期：2023
文献求助 收藏

A standardised protocol for relative SARS-CoV-2 variant severity assessment, applied to Omicron BA.1 and Delta in six European countries, October 2021 to February 2022

一项针对SARS-CoV-2变异株相对严重程度评估的标准化方案，应用于2021年10月至2022年2月期间六个欧洲国家的Omicron BA.1和Delta毒株。

期刊:Eurosurveillance
影响因子:7.8
doi:10.2807/1560-7917.ES.2023.28.36.2300048
Nyberg, Tommy; Bager, Peter; Svalgaard, Ingrid Bech; Bejko, Dritan; Bundle, Nick; Evans, Josie; Krause, Tyra Grove; McMenamin, Jim; Mossong, Joël; Mutch, Heather; Omokanye, Ajibola; Peralta-Santos, André; Pinto-Leite, Pedro; Starrfelt, Jostein; Thelwall, Simon; Veneti, Lamprini; Whittaker, Robert; Wood, John; Pebody, Richard; Presanis, Anne M
SARS-CoV-2
发表日期：2023
文献求助 收藏

Systematic evaluation of high-level visual deficits and lesions in posterior cerebral artery stroke

对后大脑动脉卒中患者的高级视觉障碍和病变进行系统性评估

期刊:Brain Communications
影响因子:4.5
doi:10.1093/braincomms/fcad050
Robotham, Ro Julia; Rice, Grace E; Leff, Alex P; Lambon Ralph, Matthew A; Starrfelt, Randi
神经科学
发表日期：2023
文献求助 收藏

Monitoring COVID-19 vaccine effectiveness against COVID-19 hospitalisation and death using electronic health registries in ≥65 years old population in six European countries, October 2021 to November 2022

利用电子健康登记系统，监测六个欧洲国家65岁及以上人群中新冠疫苗对新冠肺炎住院和死亡的有效性（2021年10月至2022年11月）。

期刊:Influenza and Other Respiratory Viruses
影响因子:4.2
doi:10.1111/irv.13195
Kislaya, Irina; Sentís, Alexis; Starrfelt, Jostein; Nunes, Baltazar; Martínez-Baz, Iván; Nielsen, Katrine Finderup; AlKerwi, Ala'a; Braeye, Toon; Fontán-Vela, Mario; Bacci, Sabrina; Meijerink, Hinta; Castilla, Jesús; Emborg, Hanne-Dorthe; Hansen, Christian Holm; Schmitz, Susanne; Van Evercooren, Izaak; Valenciano, Marta; Nardone, Anthony; Nicolay, Nathalie; Monge, Susana
肺炎
新冠
微生物学
发表日期：2023
文献求助 收藏

Age and product dependent vaccine effectiveness against SARS-CoV-2 infection and hospitalisation among adults in Norway: a national cohort study, July-November 2021

挪威成年人中，年龄和疫苗产品对SARS-CoV-2感染和住院治疗的有效性：一项全国队列研究，2021年7月至11月

期刊:BMC Medicine
影响因子:8.3
doi:10.1186/s12916-022-02480-4
Starrfelt, Jostein; Danielsen, Anders Skyrud; Buanes, Eirik Alnes; Juvet, Lene Kristine; Lyngstad, Trude Marie; Rø, Gunnar Øyvind Isaksson; Veneti, Lamprini; Watle, Sara Viksmoen; Meijerink, Hinta
炎症/感染
SARS-CoV-2
发表日期：2022
文献求助 收藏